RxDoctor Payments Data

Damien Covington, MD

Family Medicine · Midlothian, VANPI 1316912991

Payments from drug & device makers

$10,799in general payments, 2019–2025

Across 507 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$1K
  • Novo Nordisk$880
  • Lilly USA, LLC$865
  • Bayer$687
  • GSK$611
  • plus $5K from 36 others

What the payments were for

  • Food & beverage$10,43697%
  • Education$1652%
  • Gifts$1982%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,799 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$103,401
Medicare patients
206
Services billed
4,904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin89$80,434
OzempicSemaglutide54$68,202
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$45,477
FarxigaDapagliflozin Propanediol39$29,968
EliquisApixaban39$27,305
LinzessLinaclotide39$24,856
MyrbetriqMirabegron39$21,962
JanuviaSitagliptin Phosphate27$17,458
EntrestoSacubitril/Valsartan11$7,216
Albuterol Sulfate HfaAlbuterol Sulfate240$4,885
Lantus SolostarInsulin Glargine,hum.Rec.Anlog68$4,838
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate37$4,606
Diclofenac Sodium115$3,039
Atorvastatin Calcium488$2,186
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen106$2,013

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$224$80,43489 claims
Novo NordiskOzempic$880$68,20254 claims
GSKTrelegy Ellipta$611$45,47753 claims
AstraZenecaFarxiga$563$29,96839 claims
PfizerEliquis$513$27,30539 claims
AbbVieLinzess$1,247$24,85639 claims
Astellas Pharma US IncMyrbetriq$235$21,96239 claims
MerckJanuvia$65$17,45827 claims
NovartisEntresto$1,036$7,21611 claims
Scilex Pharmaceuticals Inc.Colchicine$129$1,82528 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$23$1,002104 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →